2020-05
On May 6th, Grandpharma announced that the company's wholly-owned subsidiary Grand Medical Pty Ltd (an innovative drug research and development center established by the Group in Australia) is developing a global innovative drug STC3141 for the treatment of sepsis, and recently it has been approve...
2020-03
On March 22, Grandpharma (00512.HK)announced that it was another global innovative drug in the field of sepsis after obtaining the global development and commercialization rights and interests of sepsis in research drug hip project from Australian National University (ANU) last year. It is reporte...
YOU WANT TO
